Apyx Medical Corporation (APYX), a publicly-traded company that manufactures and sells medical devices, is the subject of a class action lawsuit that has been filed on behalf of shareholders who lost money investing in the company.
Investors who bought shares of Apyx between August 1, 2018 and April 1, 2019 may be eligible to join the lawsuit.
If you are an investor and have suffered a loss with this company, you may be able to recover some of your losses.
The complaint for the lawsuit alleges that Apyx made false and misleading statements regarding its J-Plasma dermal resurfacing product. A clinical study did not have an outcome that supported the company’s application for regulatory approval of the product, and Apyx wasn’t likely to get approval to use J-Plasma in dermal resurfacing.
Due to the results of the clinical trial, Apyx’s public statements were misleading, which caused damage to investors.
If you were a Apyx Medical Corporation shareholder and want to learn more about your legal rights, contact the Silver Law Group.
Silver Law Group represents the interests of investors who have been the victims of investment fraud. Our attorneys represent investors in class actions against issuers in state or federal court and investors in securities arbitration claims against Wall Street firms for stockbroker misconduct. Scott Silver is the chairman of the Securities and Financial Fraud Group of the American Association of Justice and represents investors nationwide in securities investment fraud cases. Please contact Scott Silver of the Silver Law Group for a free consultation at firstname.lastname@example.org or toll free at (800) 975-4345.